[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100374868":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":41,"locations":51,"responsibleParty":65,"collaborators":46,"id":67,"slug":46,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":46,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":46,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":46,"overallStatus":54,"whyStopped":46,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Rifaximin","ACTIVE_COMPARATOR","550 mg Rifaximin tablets twice daily for six months.",[13],"Drug: Rifaximin",{"label":15,"type":16,"description":17,"interventionNames":18},"Nitazoxanide","EXPERIMENTAL","500 mg Nitazoxanide tablets twice daily for six months.",[19],"Drug: Nitazoxanide",[21,27],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Rifaximin 550 mg twice daily for 6 months",[9],[26],"Gastrobiotic, Trencedia",{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":30},"Nitazoxanide 500 mg twice daily for 6 months",[15],[31],"Nanazoxid",[33,36,38],{"name":34,"affiliation":5,"role":35},"Khadija Ahmed Glal, Msc","PRINCIPAL_INVESTIGATOR",{"name":37,"affiliation":5,"role":35},"Tarek Mohamed Mostafa, ass, Prof.",{"name":39,"affiliation":40,"role":35},"Sherief Abd-Elsalam, Ass. Prof.","Tanta University - Tropical Medicine Department",[42,48],{"name":43,"role":44,"phone":45,"phoneExt":46,"email":47},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440",null,"sheriefabdelsalam@yahoo.com",{"name":49,"role":44,"phone":45,"phoneExt":46,"email":50},"sherief abd-elsalam, ass. prof.","sherif_tropical@yahoo.com",[52],{"facility":53,"status":54,"city":55,"state":46,"zip":46,"country":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt",{"type":58,"coordinates":59},"Point",[60,61],31.00192,30.78847,{"lat":61,"lon":60},[64],{"name":53,"role":44,"phone":46,"phoneExt":46,"email":46},{"type":35,"investigatorFullName":53,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":46,"oldOrganization":46},"Ass. Prof. Tropical Medicine","100374868",false,"NCT04161053","Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy","Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy","Inclusion Criteria:\n\n* Cirrhotic patient with at least one previous episode of hepatic encephalopathy.\n* Adult Patients aging from 20 to 65 years old\n\nExclusion Criteria:\n\n* Active GIT bleeding.\n* Major psychiatric illness (psychosis \\& epilepsy).\n* Renal insufficiency (S.Cr 2mg\u002Fdl).","ALL","20 Years","65 Years",{"count":77,"type":78},60,"ESTIMATED","INTERVENTIONAL",[81],"PHASE3","Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.",[84],"Hepatic Encephalopathy","2019-11-12",{"date":87,"type":88},"2019-11-13","ACTUAL",{"date":90,"type":88},"2018-11-01",{"date":92,"type":78},"2028-12",{"name":5,"class":6},1]